Fundraising Fox

Nabiha Saklayen, PhD

Founder

Co-Founder & CEO at Cellino Bio

Cambridge, Massachusetts, United States

FoundedCellino Bio

About

Nabiha Saklayen is a co-founder and Chief Product & Regulatory Officer at Cellino, a venture-backed biotech company developing biomanufacturing technology to scale production of personalized iPSC-based therapies, where she leads regulatory strategy including the Advanced Manufacturing Technology designation request granted by the FDA in May 2025. She holds a PhD and MA in Applied Physics from Harvard University, where she co-invented laser-based intracellular delivery techniques, and a BSc in Biophysics from the University of California, Los Angeles, after transferring from Riverside Community College. She holds several patents, has authored peer-reviewed publications including the first review paper on autologous iPSC-based cell therapies, and was named to the Forbes 30 Under 30 2019 list for Healthcare.

Co-Founder & CEO at Cellino Bio

Intro paths

β†’

In turn, Nabiha can intro founders to Cellino Bio's investors below.

Co-founders at Cellino Bio

MM
Marinna Madrid, PhDCo-Founder & Chief Product Officer
NS
Nabiha SaklayenExecutive Officer, Director
MW
Matthias WagnerExecutive Officer, Director

Experience

  1. CellinoCo-Founder, Chief Product & Regulatory Officercurrent2026 β€” presentCambridge, Massachusetts, United States
  2. CellinoCo-Founder, Chief Product Officer2022 β€” 2026Cambridge, Massachusetts, United States
  3. CellinoCo-Founder2017 β€” 2022Cambridge, MA, USA
  4. International Society for Stem Cell ResearchCommittee Member - Manufacturing, Clinical Translation, and Regulatory Committeecurrent2024 β€” present
  5. ISCT, International Society for Cell & Gene TherapyInvited Committee Member - JSRM-ISCT iPSC Committeecurrent2022 β€” present
  6. Autologous iPSC-based Cell Therapy ConsortiumMembercurrent2020 β€” present
  7. Global Alliance for iPSC Therapies (GAiT)Invited Committee Member - Industry Liaison Committeecurrent2021 β€” present

Skills & more

Customer Service1Event Planning1Microsoft Office5Microsoft Word4Microsoft Excel1PowerPoint2Public Speaking

From Nabiha's professional profile.

Frequently asked questions

Who is Nabiha Saklayen, PhD?
Nabiha Saklayen is a co-founder and Chief Product & Regulatory Officer at Cellino, a venture-backed biotech company developing biomanufacturing technology to scale production of personalized iPSC-based therapies, where she leads regulatory strategy including the Advanced Manufacturing Technology designation request granted by the FDA in May 2025. She holds a PhD and MA in Applied Physics from Harvard University, where she co-invented laser-based intracellular delivery techniques, and a BSc in Biophysics from the University of California, Los Angeles, after transferring from Riverside Community College. She holds several patents, has authored peer-reviewed publications including the first review paper on autologous iPSC-based cell therapies, and was named to the Forbes 30 Under 30 2019 list for Healthcare.
Where does Nabiha Saklayen, PhD work?
Nabiha Saklayen, PhD is Co-Founder & CEO of Cellino Bio.
What companies did Nabiha Saklayen, PhD found?
Nabiha Saklayen, PhD founded Cellino Bio.
Where did Nabiha Saklayen, PhD go to school?
Nabiha Saklayen, PhD studied at Harvard University (PhD, Applied Physics); Riverside City College; UCLA (BS, Physics/ Biophysics).

Same school

Shared employers